Parmax Pharma Limited

Equities

PARMAX6

INE240T01014

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-06-14 am EDT			5-day change	1st Jan Change
30.03 ^INR	-3.13%		-2.28%	-7.80%

May. 02	Parmax Pharma Limited Appoints Bhakti Aghera as Company Secretary and Compliance Officer, Effective from May 02, 2024	CI
Jan. 31	Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer	CI

Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer

January 31, 2024 at 07:49 am EST

Parmax Pharma Limited announced the resignation of Mr. Yash Vora as Company Secretary & Compliance Officer with effect from 31 January, 2024.

Latest news about Parmax Pharma Limited

Parmax Pharma Limited Appoints Bhakti Aghera as Company Secretary and Compliance Officer, Effective from May 02, 2024	May. 02	CI
Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer	Jan. 31	CI
Parmax Pharma Limited Announces Resignation of Mr. Pramay Amritlal Chhatra as Director	23-04-27	CI
Parmax Pharma Limited Announces Resignation of Nikhil Uchat as Independent Director	23-04-25	CI
Parmax Pharma Limited Announces Demise of Asha Daftary, Independent Director	21-09-27	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2021	21-08-14	CI
Parmax Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	21-08-14	CI
Parmax Pharma : Managing Director Passes Away	21-04-15	MT
Parmax Pharma Limited Announces Sad Demise of Shri Alkeshbhai Gosalia, Managing Director	21-04-15	CI
Parmax Pharma Limited cancelled the transaction announced on January 16, 2021	21-02-19	CI
Parmax Pharma Limited Approves Resignation of Alkesh Gopani from the Post of Managing Director	21-02-12	CI
Parmax Pharma Limited Approves Board Resignations	21-02-12	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020	21-02-12	CI
Parmax Pharma Limited Announces Board Changes	21-02-04	CI
Parmax Pharma Limited Announces Resignation of Alkesh Gopani as Managing Director, Effective February 8, 2021	21-02-04	CI
Parmax Pharma Limited announced a financing transaction	21-01-15	CI
Parmax Pharma Limited Announces Temporary Closure of its Manufacturing Unit	20-08-25	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019	20-02-13	CI
Parmax Pharma Limited Appoints Alkesh R. Gosalia as Managing Director (Finance and Operations)	19-09-27	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2019	19-08-09	CI
Parmax Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019	19-05-30	CI
Parmax Pharma Limited Announces Resignation of Keyur Vora as Chief Financial Officer, Effective April 30, 2019	19-03-18	CI
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	19-02-14	CI
Parmax Pharma Limited Reports Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended September 30, 2018	18-11-11	CI
Parmax Pharma Limited Announces Management Changes	18-10-09	CI

Chart Parmax Pharma Limited

Duration

Period

More charts

Company Profile

Sector

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company